ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Go back to ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1| (NYSE: TAK) | Delayed: 18.91 -0.14 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.05 | 52 Week High | $0.55 | |||
| Open | $18.80 | 52 Week Low | $0.55 | |||
| Day High | $19.01 | P/E | N/A | |||
| Day Low | $18.80 | EPS | $-0.20 | |||
| Volume | 2,480,407 | |||||
